Doç. Dr. SELMAN EMİROĞLU

Yayın Ağı

Makaleler 71

1. Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in Turkiye

Karadeniz Cakmak G., Tali U., Balbaloglu H., Tasdoven I., Ozkurt E., KARANLIK H., et al.

European journal of public health , cilt.35, sa.6, ss.1271-1280, 2025 (SCI-Expanded, SSCI, Scopus)

2. Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry Study

Cabıoğlu N., Türkyılmaz Z., Özkurt E., İğci A., Müslümanoğlu M., Kapkaç M., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.26, sa.12, ss.4407-4417, 2025 (Scopus)

3. Carvacrol as a Therapeutic Candidate in Breast Cancer: Insights into Subtype-Specific Cellular Modulation.

Abuaisha A., Nekay E., Yilmaz O., Yildiz B., Mecit T., Yavas C., et al.

Biology , cilt.14, sa.10, 2025 (SCI-Expanded, Scopus)

4. Air-Assisted Mastectomy Using LigaSure for a Breast Cancer Patient With a Cardiac Pacemaker

Tukenmez M., Mollavelioglu B., Emiroglu S., Cabioglu N., Muslumanoglu M., Ozmen V.

European Journal of Breast Health , cilt.21, sa.4, ss.384-386, 2025 (ESCI)

5. Comparison of tumor clipping and marking of skin projection methods in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy: A randomized controlled trial

Kut A., EMİROĞLU S., CABIOĞLU N., Muslumanoglu M., Yilmaz R. S., Bozdogan A., et al.

MEDICINE , cilt.104, sa.36, 2025 (SCI-Expanded, Scopus)

6. Curcumin as an Epigenetic Modulator: Suppression of Breast Cancer via the Hsa_circ_0001946/MiR-7-5p/Target Gene Axis

Abuaisha A., Kaya M., Suer İ., Emiroglu S., Bayram A., Tukenmez M., et al.

MEDICINA-LITHUANIA , cilt.61, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Factors Predicting Additional Residual Nodal Disease With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy.

Cabıoğlu N., Karanlık H., Iğci A., Müslümanoğlu M., Gürsoy O. M., Tükenmez M., et al.

Journal of breast cancer , 2025 (SCI-Expanded, Scopus)

8. Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study

Cabıoğlu N., KARANLIK H., Özmen V., Tükenmez M., İğci A., Aytin Y. E., et al.

Clinical Breast Cancer , cilt.25, sa.5, ss.455-463, 2025 (SCI-Expanded, Scopus)

9. Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons.

Cabıoğlu N., Ercan D. O., Karataş İ., Eröz E., Toprak S., Emiroğlu S., et al.

Langenbeck's archives of surgery , cilt.410, sa.1, ss.196, 2025 (SCI-Expanded, Scopus)

10. Role of Lymphoscintigraphy in Repeat Sentinel Lymph Node Biopsy for cN0 Ipsilateral Breast Cancer Recurrence.

Dinçer B., Has Şimşek D., Emiroğlu S., Tükenmez M., Müslümanoğlu M., Cabıoğlu N.

Molecular imaging and radionuclide therapy , cilt.34, sa.2, ss.122-128, 2025 (ESCI) Sürdürülebilir Kalkınma

11. Omitting axillary dissection in Triple-negative and HER2-overexpressed breast cancers with positive sentinel Lymph nOdes during upfront surgery: OTHELLO Study

Cabioglu N., KARANLIK H., Ozmen V., TÜKENMEZ M., Igci A., AYTİN Y. E., et al.

CLINICAL CANCER RESEARCH , cilt.31, sa.12, 2025 (SCI-Expanded, Scopus)

12. Which surgery for breast cancer after neoadjuvant chemotherapy

Altinok P., Altinok A., Emiroǧlu S., Müslümanoǧlu M.

Indian Journal of Cancer , cilt.62, sa.2, ss.220-227, 2025 (SCI-Expanded)

13. De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer

CABIOĞLU N., Kocer H. B., KARANLIK H., Guelcelik M. A., Igci A., Muesluemanoglu M., et al.

JAMA SURGERY , cilt.160, sa.3, ss.257-266, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03

CABIOĞLU N., KARANLIK H., Igci A., Muslumanoglu M., Gulcelik M. A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03

Cabioglu N., Karanlık H., Igci A., Muslumanoglu M., Gulcelik M. A., Uras C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.32, sa.2, ss.952-966, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Evaluating the efficacy of preoperative radiotherapy in breast cancer patients non-responsive to neoadjuvant chemotherapy: A clinical trial

Muslumanoglu M., Ozkurt E., EMİROĞLU S., İBİŞ K., Abuaisha A., TÜKENMEZ M., et al.

BIOMEDICAL RESEARCH AND THERAPY , sa.12, ss.6978-6988, 2025 (ESCI)

17. Let-7b-5p sensitizes breast cancer cells to doxorubicin through Aurora Kinase B

Kaya M., Abuaisha A., Suer İ., Emiroglu S., Önder S., Onay Ucar E., et al.

PLOS ONE , cilt.20, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Two potential regulatory axes in breast cancer patients: hsa_circ_0001546/hsa-miR-532-5p/ZFHX3 and hsa_circ_0025244/hsa-miR-210-5p/BTG2

Abanoz F., Suer İ., Kaya M., Abuaisha A., Emiroğlu S., Öztürk Ş.

CUKUROVA MEDICAL JOURNAL , cilt.50, sa.3, ss.782-795, 2025 (ESCI, TRDizin)

19. Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided

Muslumanoglu M., Cabioglu N., Igci A., Karanlık H., Kocer H. B., Senol K., et al.

CANCER , cilt.131, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy

Cabıoğlu N., KARANLIK H., Yılmaz R. S., Emiroğlu S., Tükenmez M., BADEMLER S., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy

Muslumanoglu M., Mollavelioglu B., Cabioglu N., Emiroglu S., Tukenmez M., Karanlık H., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Overexpression of CDC25A, AURKB, and TOP2A Genes Could Be an Important Clue for Luminal A Breast Cancer.

Kaya M., Abuaisha A., Süer İ., Alptekin M. S., Abanoz F., Emiroğlu S., et al.

European journal of breast health , cilt.20, sa.4, ss.284-291, 2024 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

23. EFFECT of CURCUMIN on BREAST CANCER CELLS THROUGH miR-145-5p AND ITS TARGET GENES

Abuaisha A., Kaya M., Suer İ., Emiroğlu S., Abanoz F., Palanduz Ş., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , sa.3, ss.235-245, 2024 (ESCI, TRDizin) Sürdürülebilir Kalkınma

24. Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets

Kaya M., Abuaisha A., Suer İ., Emiroglu S., Abanoz F., Palanduz S., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.20, sa.2, ss.102-109, 2024 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

25. Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results

Bozdogan A., Emiroglu S., Abuaisha A., DENİZ BAŞAR Ö.

Archives of Breast Cancer , cilt.11, sa.1, ss.67-74, 2024 (Scopus) Sürdürülebilir Kalkınma

26. A Novel Surgical Technique for Gynecomastia: Air-Assisted Minimally Invasive Surgery With Single Axillary Incision

Tukenmez M., Mollavelioglu B., Kozanoglu E., Emiroglu S., Cabioglu N., Muslumanoglu M.

SURGICAL INNOVATION , cilt.31, sa.1, ss.5-10, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. DIAGNOSIS AND ENDOVASCULAR TREATMENT OF AN ARTERIOVENOUS FISTULA IN THE BREAST MEMEDE ARTERİYOVENÖZ FİSTÜL OLGUSUNUN TANI VE ENDOVASKÜLER TEDAVİSİ

Cömert R. G., Çakir M. S., Yilmaz R., Emi̇roğlu S., Acunaş B.

Istanbul Tip Fakultesi Dergisi , cilt.87, sa.1, ss.95-100, 2024 (ESCI, Scopus, TRDizin)

28. The Effect of Adjuvant Therapies for Recurrence in Stage I Breast Cancer Patients: A Single Centre Experience

Doğan İ., Khanmammadov N., Aydin E., PAKSOY N., Ferhatoğlu F., AK N., et al.

Turk Onkoloji Dergisi , cilt.39, sa.3, ss.257-264, 2024 (ESCI, Scopus, TRDizin)

29. Delayed Port Site Recurrence from Gallbladder Dysplasia Following Laparoscopic Cholecystectomy: All Gallbladder Retrieval Always Be Inside a Bag?

Kara M., Erdoğdu E., BÜYÜK M., Emiroğlu S.

INDIAN JOURNAL OF SURGERY , cilt.85, sa.6, ss.1482-1484, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

30. Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients

DOĞAN İ., Aydin E., KHANMAMMADOV N., Paksoy N., Ferhatoğlu F., AK N., et al.

Journal of Cancer Research and Clinical Oncology , cilt.149, sa.16, ss.14833-14841, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Pregnancy-associated breast malignancy mostly presents with an aggressive type of breast cancer

ACAR İ., Ercan L. D., EMİROĞLU S., TÜKENMEZ M., EMİROĞLU B., Muslumanoglu M., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , sa.5, ss.1-10, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Effect of Cold Therapy on Managing Postoperative Pain Following Breast Conserving Surgery

Emiroglu S., Esen E., Yalcin N., Azizoglu F. S., Zent N., Bozdogan A., et al.

PAIN MANAGEMENT NURSING , cilt.24, sa.4, ss.452-455, 2023 (SCI-Expanded, SSCI) Sürdürülebilir Kalkınma

33. Pure Tubular Breast Carcinoma: Clinicopathological Characteristics and Clinical Outcomes

Emiroglu S., Abuaisha A. M., Tukenmez M., Cabioglu N., Bayram A., Ozmen V., et al.

European Journal of Breast Health , cilt.19, sa.2, ss.115-120, 2023 (Scopus)

34. Evaluation of Benign Breast Diseases with or without Atypical Epithelial Hyperplasia Accompanying Radial Scars

Turkyilmaz Z., Sarisik E., Ozkurt E., Tukenmez M., Emiroglu S., Emiroglu B., et al.

European Journal of Breast Health , cilt.19, sa.2, ss.166-171, 2023 (Scopus, TRDizin)

35. Evaluation of Breast Cancer Risk, Fear and Knowledge Levels and their Effect on Examination Behaviors

Emiroglu S.

Journal of Medical and Health Studies , cilt.4, sa.2, ss.59-65, 2023 (Hakemli Dergi)

36. Single axillary incision endoscopic surgery and liposuction for gynecomastia

Tukenmez M., Emiroglu S., Kozanoglu E., Akalin B. E., Mollavelioglu B., Cabioglu N., et al.

Medicine (United States) , cilt.102, sa.7, 2023 (SCI-Expanded, Scopus)

37. Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacy

Cabioglu N., URAS C., Mutlu H., Sezgin D., Emiroglu S., DÜLGEROĞLU O., et al.

Frontiers in Medicine , cilt.10, 2023 (SCI-Expanded, Scopus)

38. Surgery for phyllodes tumour of the breast. What should be surgical margins?

Tukenmez M., Mollavelioglu B., Onder S., Emiroglu S., VELİDEDEOĞLU M., ERGÜN S., et al.

ANZ Journal of Surgery , cilt.93, sa.1-2, ss.257-262, 2023 (SCI-Expanded, Scopus)

39. Ozone therapy restores immune dysfunction in refractory idiopathic granulomatous mastitis as a novel potential therapeutic approach

Cabioglu N., Aktas E., Emiroglu S., Tukenmez M., Ozkurt E., Muslumanoglu M., et al.

CELL BIOLOGY INTERNATIONAL , cilt.47, sa.1, ss.228-237, 2023 (SCI-Expanded, Scopus)

40. Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis

Cabioglu N., Trabulus D. C., Emiroglu S., Ozkurt E., Yalcin N., Dinc N., et al.

Frontiers in Medicine , cilt.10, 2023 (SCI-Expanded, Scopus)

41. Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

CABIOĞLU N., BAYRAM A., EMİROĞLU S., ÖNDER S., Karatay H., Oner G., et al.

FRONTIERS IN ONCOLOGY , cilt.13, 2023 (SCI-Expanded, Scopus)

42. Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?

Emiroglu S., Özkurt E., Cabıoglu N., Igci A., Saip P., YAZICI H., et al.

Breast Cancer: Targets and Therapy , cilt.15, ss.163-173, 2023 (SCI-Expanded, Scopus)

43. Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes

Özkurt E., Emiroğlu S., Cabioğlu N., Karanlık H., Önder S., Tükenmez M., et al.

BREAST CARE , cilt.17, sa.6, ss.554-560, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer

Has Simsek D., Emiroglu S., Yilmaz R. S., Bayram A., Isik E. G., Tukenmez M., et al.

CLINICAL NUCLEAR MEDICINE , cilt.47, sa.11, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

45. Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes

EMİROĞLU S., Tukenmez M., Karakus S., KARANLIK H., Onder S., Ozmen V., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.18, sa.4, ss.353-359, 2022 (ESCI, Scopus, TRDizin)

46. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer

MOLLAVELİOĞLU B., ÇETİN E., CABIOĞLU N., Abbasov A., ÖNDER S., EMİROĞLU S., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.20, sa.1, 2022 (SCI-Expanded, Scopus)

47. Abbreviated and Standard Breast MRI in Neoadjuvant Chemotherapy Response Evaluation: A Comparative Study

Yirgin İ., Engin G., Yildiz Ş., Aydin E. C., Karanlik H., Cabioglu N., et al.

CURRENT MEDICAL IMAGING , cilt.18, sa.10, ss.1052-1060, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Efficacy of preoperative radiotherapy for non-responder breast cancer patients following to neoadjuvant chemotherapy

Muslumanoglu M., Emiroglu S., Ozkurt E., Ozkurt S., Kucucuk S., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.288, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

49. Topografic localisation is enough for correct excision following neoadjuvant chemotherapy in nonpalpable breast cancer

Muslumanoglu M., Emiroglu S., Mollavelioglu B., Atalay B., Yanik M., Yilmaz R., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.171, 2022 (SCI-Expanded, Scopus)

50. The American Society of Breast Surgeons Official Proceedings, Volume XXIII 2022 Annual Meeting Scientific Session Abstracts

Müslümanoğlu M., Özkurt S., Emiroğlu S., Özkurt E., Küçücük S., Tükenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.S1, ss.288, 2022 (SCI-Expanded)

51. Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?

Cabioglu N., Karanlik H., Igci A., Muslumanoglu M., Tukenmez M., Emiroglu S., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.310-311, 2022 (SCI-Expanded, Scopus)

52. Sentinel lymph node biopsy with/without axillary dissection in clinically node-positive breast cancer after neoadjuvant chemotherapy

Cabioglu N., Karanlik H., Gulcelik M. A., Ilgun S., Igci A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.69-70, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

53. Poor Outcome in Pregnancy-associated Breast Cancer among Turkish Women:An aggressive type of breast carcinoma

Acar I., Yıldırım D. O., Emiroğlu S., Tükenmez M., Müslümanoğlu M., İğci A., et al.

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY , cilt.48, sa.2, ss.57, 2022 (Scopus)

54. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study

Cabıoğlu N., Karanlık H., Yıldırım N., Müslümanoğlu M., Çakmak Karadeniz G., Trabulus Can D., et al.

EJSO , sa.10, ss.2506-2514, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Ozone Therapy as a Novel Potential Approach in Patients with Severe Granulomatous Mastitis Is Associated with an Improved T-helper-1 Response

Cabioglu N., Aktas E., Emiroglu S., Tukenmez M., Dinc N., Muslumanoglu M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, 2021 (SCI-Expanded)

56. Efficacy of Ozone Therapy as a Novel Potential Therapeutic Approach in Severe Granulomatous Mastitis

Cabioglu N., Trablus D. C., Yalcin N., Emiroglu S., Dinc N., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, 2021 (SCI-Expanded)

57. Is There Any Advantage of Targeted Axillary Dissection After Neoadjuvant Chemotherapy in Patients with Initially Positive Clipped Node?

Cabioglu N., Karanlik H., Yilmaz R., Emiroglu S., Dursun M., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.SUPPL 2, 2021 (SCI-Expanded, Scopus)

58. Sentinel lymph node biopsy alone in locally advanced breast cancer after neoadjuvant chemotherapy: Turkish multicentric neosenti-turk MF-18-02-study

Cabioglu N., Karanlik H., Muslumanoglu M., Cakmak G. K., Trablus D. C., Tukenmez M., et al.

CANCER RESEARCH , cilt.81, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. Report of Two Cases with Simultaneously Detected Tubular Carcinoma and Phyllodes Tumor of the Breast

İLHAN M. B., EMİROĞLU S., Turkay R.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.17, sa.1, ss.80-83, 2021 (ESCI, TRDizin)

60. Differential expression of novel immune checkpoint receptors on tumor-infiltrating lymphocytes in patients with locally advanced breast cancer after neoadjuvant chemotherapy

Abbasov A., Aktas Cetin E., Cabioglu N., Mollavelioglu B., Onder S., Emiroglu S., et al.

NEOPLASMA , sa.5, ss.1079-1090, 2021 (SCI-Expanded, Scopus)

61. Differential expressions of immune check point receptors on tumor infiltrating lymphocytes after neo-adjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC)

Abbasov A., ÇETİN E., CABIOĞLU N., MOLLAVELİOĞLU B., ÖNDER S., EMİROĞLU S., et al.

CANCER RESEARCH , cilt.80, sa.16, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

62. The role of histopathologic testing on apocrine carcinoma of the breast

Ilhan B., Emiroglu S., Turkay R., Ilhan R.

CURRENT PROBLEMS IN CANCER , cilt.44, sa.2, 2020 (SCI-Expanded, Scopus)

63. Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery

Cakmak G. K., Emiroglu S., Sezer A., Cantürk N. Z., Yeniay L., Kuru B., et al.

JCO GLOBAL ONCOLOGY , cilt.6, ss.285-292, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma

64. Discussing treatment strategies for acute mechanical intestinal obstruction caused by phytobezoar: A single-center retrospective study.

Gök A., Sönmez R., Kantarcı T. R., Bayraktar A., Emıroğlu S., İlhan M., et al.

Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES , cilt.25, sa.5, ss.503-509, 2019 (SCI-Expanded, Scopus, TRDizin)

65. Surgical treatment of post-transplant encapsulating peritoneal sclerosis: A single-center experience Böbrek nakli sonrası gelişen enkapsüle periton sklerozunda cerrahi tedavi: Tek merkez deneyimi

Bayraktar A., Gök A. F. K., Emiroğlu S., Bakkaloğlu H.

Ulusal Travma ve Acil Cerrahi Dergisi , cilt.25, ss.142-146, 2019 (SCI-Expanded, Scopus, TRDizin)

66. Laparoscopic versus open appendectomy in pregnancy: A single center experience

Gök A., Soydaş Y., Bayraktar A., Emırıkçı S., İlhan M., Koltka A. K., et al.

ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY , cilt.24, sa.6, ss.552-556, 2018 (SCI-Expanded, Scopus, TRDizin)

67. Encapsulated Papillary Carcinoma in A Man with Gynecomastia: Ultrasonography, Mammography and Magnetic Resonance Imaging Features with Pathologic Correlation

Yilmaz R. S., Comert R. G., Aliyev S., Toktas Y., Onder S., Emirikci S., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.14, sa.2, ss.127-131, 2018 (ESCI, TRDizin) Sürdürülebilir Kalkınma

68. MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses

YıLMAZ R. S., BAYRAMOGLU Z., EMIRIKÇI S., ÖNDER S., Salmaslıoğlu A., DURSUN M., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , sa.1, ss.39-45, 2018 (ESCI, TRDizin) Sürdürülebilir Kalkınma

69. Over Matür Kistik Teratomu İçerisinde İnsidental Olarak Saptanan Tiroid Papiller Kanserine Yaklaşım

Öner G., Özçınar B., Emirikçi S., Yanar F., Güngör Uğurlucan F., Erbil Y.

Causapedia , cilt.5, sa.3, ss.151-154, 2016 (Hakemli Dergi) Sürdürülebilir Kalkınma

70. Thyroid cancer incidence in simultaneous thyroidectomy with parathyroid surgery

Emirikci S., Ozcinar B., Oner G., Omarov N., Agcaoglu O., Soytas Y., et al.

TURKISH JOURNAL OF SURGERY , cilt.31, sa.4, ss.214-217, 2015 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

71. Falling television related child injuries in Turkey: 10-year experience

Guloglu R., Sarici I. S., Bademler S., Emirikci S., Issever H., Yanar H. T., et al.

ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY , sa.1, ss.61-64, 2012 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 47

1. AİLE ÖYKÜSÜ POZİTİF MEME KANSERLİ HASTALARDA NÜKS ORANI TOPLUM SIKLIĞINDAN YÜKSEK MİDİR?

Erdönmez Çelik A. H., Mollavelioğlu B., Emiroğlu S., Tükenmez M., Cabıoğlu N., Müslümanoğlu M. E.

18. Ulusal Meme Hastalıkları Kongresi, Girne, Kıbrıs (Kktc), 27 - 30 Kasım 2025, (Yayınlanmadı)

2. One-Year Patient Reported Outcomes and Lymphedema in Node-Positive Breast Cancer in the Prospective Multicenter Neosenti-Turk/MF-18-03 study: Is there any benefit of Targeted Axillary Dissection over Sentinel Lymph Node Biopsy?

CABIOĞLU N., GÜL KILIÇ H., KAMALI POLAT A., USLU Y., Kılıç B., Bozdoğan A., et al.

26th Annual Meeting of the American-Society-of-Breast-Surgeons (ASBrS), Las vegas, Amerika Birleşik Devletleri, 30 Nisan 2025, cilt.32, ss.579-580, (Özet Bildiri) Sürdürülebilir Kalkınma

3. PATIENT REPORTED OUTCOMES AND LYMPHEDEMA IN NODE-POSITIVE BREAST CANCER IN THE EARLY POSTOPERATIVE PERIOD AFTER NEOADJUVANT CHEMOTHERAPY IN THE PROSPECTIVE NEOSENTITURK-trial MF18-03

CABIOĞLU N., GÜL KILIÇ H., Bozdoğan A., Rumisa Kılıç B., USLU Y., EMİROĞLU S., et al.

San Antonio Breast Cancer Symposium, New York, Amerika Birleşik Devletleri, 10 Aralık 2024, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

4. GENETIC VARIANTS OF UNCERTAIN SIGNIFICANCE IN DLC1 AND PRLR GENES IN A PURE MUCINOUS BREAST CARCINOMA PATIENT

Abuaisha A., SUER İ., Kaya M., EMİROĞLU S., TÜKENMEZ M., ÖZTÜRK Ş.

TASHKENT INTERNATIONAL CONGRESS ON MODERN SCIENCES-III, Taşkent, Özbekistan, 22 - 23 Nisan 2024, (Özet Bildiri)

5. Curcumin inhibits breast cancer cell proliferation by regulating ciRS-7/miR-7-5p/CKS2 axis

Abuaisha A., Kaya M., SUER İ., EMİROĞLU S., Abanoz F., TÜKENMEZ M., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, (Özet Bildiri)

6. Imaging tailored axillary approach combined with radiotherapy eliminates axillary lymph node dissection in low-volume axillary disease after neoadjuvant chemotherapy

Muslumanoglu M., MOLLAVELİOĞLU B., EMİROĞLU S., KARANLIK H., Tukenmez M., İBİŞ K., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, cilt.84, (Özet Bildiri)

7. PMRT Decision with low prediction of genomic test score in pT3N0M0 luminal breast cancer: Protocol MF22-02: International multicenter realworld data

Soran A., King C., Barry P. N., Bhargava R., KARANLIK H., Gultekin M., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, (Özet Bildiri)

8. Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study

Cabioglu N., KARANLIK H., Gulcelik M. A., Kocer H. B., Muslumanoglu M., Igci A., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, (Özet Bildiri)

9. PATIENT REPORTED OUTCOMES IN TERMS OF ARM AND SHOULDER FUNCTIONS AND QUALITY OF LIFE AND LYMPHEDEMA ARE AFFECTED BY THE STAGE, AND EXTENT OF AXILLARY SURGERY IN THE EARLY POSTOPERATIVE PERIOD OF PATIENTS WITH BREAST CANCER

Kilic H. G., EMİROĞLU S., Ozgorgu E., Tukenmez M., Bozdogan A., Muslumanoglu M., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, (Özet Bildiri)

10. Combined Analysis of the MF18-02/03 Neosentiturk Studies: Factors Predicting Recurrence in ycN0/ypN-positive Breast Cancer with Sentinel Lymph Node Biopsy - Or Targeted Axillary Dissection - Alone After Neoadjuvant Chemotherapy

Cabioglu N., Muslumanoglu M., Igci A., KARANLIK H., TÜKENMEZ M., Gulcelik M. A., et al.

24th Annual Meeting of The American Society of Breast Surgeons (ASBrS), Mississippi, Amerika Birleşik Devletleri, 26 - 30 Nisan 2023, (Özet Bildiri) Sürdürülebilir Kalkınma

11. Local Steroid Injection in Severe Idiopathic Granulomatous Mastitis as a New First-line Treatment Modality with Promising Therapeutic Efficacy

Cabioglu N., URAS C., EMİROĞLU S., Sezgin D. S., Mutlu H., TÜKENMEZ M., et al.

24th Annual Meeting of The American Society of Breast Surgeons (ASBrS), Mississippi, Amerika Birleşik Devletleri, 26 - 30 Nisan 2023, (Özet Bildiri)

12. AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03

Cabioglu N., KARANLIK H., Gulcelik M. A., Igci A., Muslumanoglu M., Kocer H. B., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 6 - 10 Aralık 2022, (Özet Bildiri)

13. BLOOD SERUM AND PLASMA WITH STRIKING GREEN COLOR IN BREAST CANCER PATIENTS

Abuaisha A., EMİROĞLU S., Kaya M., SUER İ., CABIOĞLU N., ÖZTÜRK Ş.

International Congress on Innovative Approaches in Medical and Health Sciences, Türkiye, 13 - 14 Ağustos 2022, ss.514, (Özet Bildiri)

14. A RARE CASE OF MUCINOUS CARCINOMA OF THE BREAST IN A 30-YEAR-OLD FEMALE

EMİROĞLU S., Abuaisha A., TÜKENMEZ M., Kaya M., SUER İ., BAYRAM A., et al.

4th International Congress on Medical Sciences and Multidisciplinary Approaches, İstanbul, Türkiye, 26 Mart - 28 Ağustos 2022, cilt.1, ss.302-308, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

15. A Rare Case Of Mucınous Carcınoma Of The Breast In A 30-Year-Old Female

EMİROĞLU S., ABUAISHA A. M., TÜKENMEZ M., KAYA M., SÜER İ., BAYRAM A., et al.

4. ULUSLARARASI TIP BİLİMLERİ VE MULTİDİSİPLİNER YAKLAŞIMLAR KONGRESİ, 26 - 28 Mart 2022, (Tam Metin Bildiri)

16. Türkiye'de Genel Cerrahlar Arasında Aksila Pozitif Lokal İleri Meme Kanseri Hastalarda Aksilla Yönetimi: MF17-01 Çalışması

KARATAŞ İ., CABIOĞLU N., EMİROĞLU S., ERCAN L. D., ÖZKURT E., TOPRAK S., et al.

22. Ulusal Cerrahi Kongresi ve 17. Ulusal Cerrahi Hemşireliği Kongresi, Antalya, Türkiye, 23 - 27 Mart 2022, (Özet Bildiri)

17. Tıkayıcı Çekum Tümörünü Taklit Eden Tüberküloz Peritonitis Olgusu

KANTARCI T. R., GÜNAY M., Abbasov A., GÖK A. F. K., EMİROĞLU S., İLHAN M., et al.

22. Ulusal Cerrahi Kongresi ve 17. Ulusal Cerrahi Hemşireliği Kongresi, Antalya, Türkiye, 23 - 27 Mart 2022, (Özet Bildiri)

18. Meme Kanserinde Aksiller Cerrahinin Nadir Bir Komplikasyonu: Şilöz Kaçak

Güden I., Çelik A., Emiroglu S., Cabıoglu N.

22.Ulusal Cerrahi Kongresi 23-27 Mart 2022, Antalya, Türkiye, 23 - 27 Mart 2022, ss.1-2, (Özet Bildiri)

19. Factors predicting a lower likelihood of residual nodal disease in clinically-node positive patients undergoing sentinel node surgery after neoadjuvant chemotherapy for breast cancer

Cabioglu N., KARANLIK H., Igci A., Muslumanoglu M., TÜKENMEZ M., EMİROĞLU S., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 7 - 10 Aralık 2021, (Özet Bildiri)

20. MEME KANSERLİ HASTALARDA NEOADJUVAN TEDAVİ SONRASI PATOLOJİK YANITIN ÖNGÖRÜLMESİNDE 18F-FDG PET/BT’NİN ROLÜ

Oflas M., Has Şimşek D., Işık E. G., Emirikçi S., Cabıoğlu N., Müslümanoğlu M. E., et al.

33. Ulusal Nükleer Tıp Kongresi, İstanbul, Türkiye, 28 - 29 Mayıs 2021, ss.10-11, (Özet Bildiri)

21. Ozone Therapy as a Novel Potential Approach in Patients with Severe Granulomatous Mastitisis associated with an improved T-helper-1 response

Cabioğlu N., Çetin E., Emiroğlu S., Özkurt E., Tükenmez M., Müslümanoğlu M., et al.

22nd ASBrS Annual meeting, District Of Columbia, Amerika Birleşik Devletleri, 29 Nisan - 02 Mayıs 2021, ss.1, (Özet Bildiri)

22. İSOSÜLFAN MAVİSİNE BAĞLI NADİR OLARAK GÖRÜLEN ANAFİLAKTOİD REAKSİYONU: 4 OLGU DENEYİMİMİZ

Kut A., Günay M., Emiroğlu S., Tükenmez M., Cabıoğlu N., Müslümanoğlu M. E., et al.

15. Ulusal Meme Hastalıkları Kongresi, Antalya, Türkiye, 17 - 20 Ekim 2019, ss.164, (Özet Bildiri) Sürdürülebilir Kalkınma

23. Sentinel lymph node biopsy alone in locally advanced breast cancer after neoadjuvant chemotherapy: Turkish multicentric neosenti-turk MF-18-02-study.

CABIOĞLU N., KARANLIK H., MÜSLÜMANOĞLU M. E., KARADENİZ ÇAKMAK G., Can Trablus D., TÜKENMEZ M., et al.

SABCS 2020, Amerika Birleşik Devletleri, 08 Kasım 2020, (Özet Bildiri)

24. Is There Any Advantage of Targeted Axillary Dissection After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer with Initially Positive Clipped Axillary Node?

CABIOĞLU N., Karanlik H., Yilmaz R. S., EMİROĞLU S., Dursun M., TÜKENMEZ M., et al.

21st Annual Meeting of the American-Society-of-Breast-Surgeons (ASBS), Nevada, Amerika Birleşik Devletleri, 29 Nisan - 03 Mayıs 2020, cilt.27, (Özet Bildiri)

25. Differential expression of novel immune checkpoint receptors expressed on tumor-infiltrating lymphocytes (TIL) in patients with early breast cancer

MOLLAVELİOĞLU B., Cetin E. A., CABIOĞLU N., Abbasov A., ÖNDER S., EMİROĞLU S., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 10 - 14 Aralık 2019, cilt.80, (Özet Bildiri) Sürdürülebilir Kalkınma

26. LOKAL İLERİ MEME KANSERLİ HASTALARDA NEOADJUVAN KEMOTERAPİ SONRASI PD-1, CTLA-4 POZİTİF TÜMÖR İNFİLTRE EDEN LENFOSİT EKSPRESYONUNUN KLİNİK ÖNEMİ VARMI?

Abbasov A., ÇETİN E., CABIOGLU N., MOLLAVELİOĞLU B., ÖNDER S., EMİROĞLU S., et al.

15. Ulusal Meme Hastalıkları Kongresi, Antalya, Türkiye, 6 - 10 Kasım 2019, ss.109, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

27. MEME KANSERİ BÖLGESEL LENF NODU NÜKSÜ: UZUN DÖNEM SONUÇLARIMIZ

ERCAN L. D., KARATAŞ İ., EMİROĞLU S., TÜKENMEZ M., ÖZMEN V., müslümanoğlu M., et al.

15. ULUSAL MEME HASTALIKLARI KONGRESİ, 17 - 20 Ekim 2019, (Özet Bildiri)

28. LOCAL LYMPH NODE RECURRENCE OF BREAST CANCER: LONG TERM RESULTS

ERCAN L. D., KARATAŞ İ., EMİROĞLU S., TÜKENMEZ M., ÖZMEN V., MÜSLÜMANOĞLU M., et al.

15. ULUSAL MEME HASTALIKLARI KONGRESİ, 17 - 20 Ekim 2019, (Özet Bildiri)

29. KAS ÖNÜ İMPLANT İLE YAPILAN REKONSTRÜKSYON MEME KANSERİ CERRAHİSİNDE YATIŞ SÜRELERİNİ KISALTAN ETKİN BİR YÖNTEMDİR

Müslümanoğlu M. E., Emiroğlu S., Günay M., Tükenmez M., Cabıoğlu N., Özmen V.

15. Ulusal Meme Hastalıkları Kongresi, Antalya, Türkiye, 17 - 20 Ekim 2019, ss.176-177, (Özet Bildiri) Sürdürülebilir Kalkınma

30. BAŞLANGIÇ KLİNİK AKSİLLA POZİTİF LOKAL İLERİ MEME KANSERLİ HASTALARDA KLİPSLİ LENF NODUNUN HEDEFLENEREK ÇIKARILMASININ NEOADJUVAN KEMOTERAPİ SONRASI AKSİLLER GİRİŞİME KATKISI VAR MI?

CABİOĞLU N., KARANLIK H., YILMAZ R. S., DURSUN M., EMİRİKÇİ S., TÜKENMEZ M., et al.

. 15. Ulusal Meme Hastalıkları Kongresi, Antalya, Türkiye, 17 - 20 Ekim 2019, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

31. .Neoadjuvan Kemoterapi Yanıtının Değerlendirilmesinde Kısaltılmış ve Standart Diagnostik Meme MR Protokollerinin Diagnostik Değerlerinin Karşılaştırılması.

KIZILDAĞ YIRGIN İ., YILDIZ Ş., ENGİN G., CABİOĞLU N., KARANLIK H., TÜKENMEZ M., et al.

. 15. Ulusal Meme Hastalıkları Kongresi, Antalya, Türkiye, 17 - 20 Ekim 2019, (Tam Metin Bildiri)

32. Favorable local control in breast cancer patients following sentinel lymph node biopsy after neoadjuvant chemotherapy without axillary lymph node dissection

Cabioglu N., Igci A., Karanlik H., Muslumanoglu M., Cakmak G. K., Emirikci S., et al.

20th Annual Meeting of the American-Society-of-Breast-Surgeons, Texas, Amerika Birleşik Devletleri, 30 Nisan - 05 Mayıs 2019, cilt.26, ss.292-293, (Özet Bildiri) Sürdürülebilir Kalkınma

33. NADİR KARŞILAŞILAN ACİL BOCHDALEK HERNİSİ VAKASINA MİNİMAL İNVAZİV YAKLAŞIM: OLGU SUNUMU

HÜSEYNOV E., EMİROĞLU S., GÜNAY M., ERÖZ E., GÖK A. F. K.

14. Endoskopik Laparoskopik Cerrahi Kongresi, BAFRA, Kıbrıs (Kktc), 19 - 22 Nisan 2019, (Özet Bildiri)

34. Long-term effective local control in patients presenting with T4 disease and treated with breast-conserving therapy after neoadjuvant chemotherapy

Tukenmez M., Trablus D. C., Ozkurt E., Cabioglu N., Dogan S., Emirikci S., et al.

19th Annual Meeting of the American-Society-of-Breast-Surgeons, Florida, Amerika Birleşik Devletleri, 2 - 06 Mayıs 2018, cilt.25, ss.530-531, (Özet Bildiri)

35. THE ROLE OF MRI FINDINGS WITH DIFFUSION-WEIGHTED IMAGING IN THE DIFFERENTIATING PURE MUCINOUS CARCINOMAS FROM FIBROADENOMAS

YILMAZ R. S., AKKAVAK G., AKPINAR Y. E., BAYRAMOĞLU Z., emirikçi S., TÜKENMEZ M.

TÜRK MANYETİK REZONANS DERNEĞİ 23.YILLIK BİLİMSEL TOPLANTISI, Ankara, Türkiye, 10 - 12 Mayıs 2018, (Tam Metin Bildiri)

36. Neoadjuvan kemoterapi sonrası meme koruyucu cerrrahi planlanan hastalarda tümör yanıtını saptamada magnetik rezonans görüntülemenin ve tümör karakteristiklerinin cerrahi eksizyonu planlamada önemi

CAN TRABULUS D., YILMAZ R. S., ÖZKURT E., TÜKENMEZ M., emirikçi S., ÖZMEN V., et al.

14. Ulusal Meme Hastalıkları Kongresi, Türkiye, 19 - 22 Ekim 2017, (Özet Bildiri)

37. Laparoscopic Treatment of Median Arcuat Ligamen Syndrome: A New Aproach

ÖZKURT E., SOYTAŞ Y., SARICI İ. Ş., EMİROĞLU S., BULAKÇI M., MÜSLÜMANOĞLU M.

24th International Congress of the European Association for Endoscopic Surgery (EAES) Amsterdam, The Netherlands, 15–18 June 2016, Hollanda, 15 - 18 Haziran 2016, (Özet Bildiri)